ImmunoBiome Inc.
PrivateLast Round
Series B
Jan 1, 2022
Total Funding Raised
$23.81M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ImmunoBiome Inc. operates in Healthcare & Life Sciences and is based in Pohang. Its latest recorded funding round was a Series B round in January 2022.
ImmunoBiome Inc. is a biotechnology company that develops microbiome-targeted therapeutics and live biotherapeutic products (LBPs) for incurable diseases such as cancer, autoimmune disorders, and autism spectrum disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmunoBiome Inc. Comparables
Compare ImmunoBiome Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enterobiome Inc. | 87% | |
| Exeliom Biosciences | 81% | |
| PharmaBiome | 80% |
For institutional investors. Book with your work email.
ImmunoBiome Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 1, 2022 | ||||
| Series A | Sep 1, 2020 | ||||
| Pre Seed | Dec 1, 2019 | ||||
| Seed | Jul 1, 2019 |
For institutional investors. Book with your work email.
ImmunoBiome Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea Investment Partners | Series B, Series A |
| Company K Partners | Series B |
| Brain Asset Management Co.,Ltd. | Series B |
| Korea Investment & Securities | Series B |
| Union Investment Partners | Series B |
| KTB Investment Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 398, 1895% of headcount.
- Jul 26, 2026
Monthly visitors grew 192% MoM, from 386 to 1.1K.
For institutional investors. Book with your work email.
ImmunoBiome Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ImmunoBiome Inc.'s valuation, stock price, and market status.
Is ImmunoBiome Inc. a public or private company?
ImmunoBiome Inc. is a private company.
What is the current stock price of ImmunoBiome Inc.?
ImmunoBiome Inc. is a private company, so its shares have no public market price. Caplight tracks ImmunoBiome Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ImmunoBiome Inc. worth (valuation)?
Valuation information for ImmunoBiome Inc. is not publicly available.
Can I buy ImmunoBiome Inc. stock?
ImmunoBiome Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ImmunoBiome Inc.'s last funding round?
ImmunoBiome Inc.'s most recent funding round was Series B on January 1, 2022.
Who are the main investors in ImmunoBiome Inc.?
Key investors in ImmunoBiome Inc. include Korea Investment Partners.
Will ImmunoBiome Inc. IPO soon?
No public IPO plans have been announced for ImmunoBiome Inc..
How can I track ImmunoBiome Inc. secondary market activity?
Caplight tracks bids, offers, and trades in ImmunoBiome Inc.'s shares on secondary markets.